Clinical Trials on Carbohydrate Metabolism at Exercise in United States
Total 2980 results
-
Oregon Health and Science UniversityUniversity of Oregon; Oregon State UniversityRecruitingCarbohydrate IntoleranceUnited States
-
University of FloridaCompleted
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Vitaflo International, LtdUniversity College London Hospitals; University Medical Center Groningen; University... and other collaboratorsCompletedGlycogen Storage DiseaseUnited States, United Kingdom, France, Netherlands
-
Augusta UniversityUnknownFructose IntoleranceUnited States
-
University of FloridaDiabetes SentryTerminatedClinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease PopulationGlycogen Storage DiseaseUnited States
-
Augusta UniversityUniversity of Iowa; Teikyo UniversityRecruitingFructose IntoleranceUnited States
-
Virginia Polytechnic Institute and State UniversityRecruiting
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS)Enrolling by invitationCongenital Disorders of GlycosylationUnited States
-
Tulane UniversityCompletedCongenital Disorders of GlycosylationUnited States
-
Augusta UniversityTerminatedDietary Fructose IntoleranceUnited States
-
Mayo ClinicRecruitingCongenital Disorder of GlycosylationUnited States
-
Grace Science, LLCRecruitingNGLY1 DeficiencyUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Duke UniversitySuspendedLysosomal Storage Diseases | Genetic Disease | Inborn Errors of Metabolism | Glycogen Storage Disease | Storage DiseaseUnited States
-
Areeg El-GharbawyUltragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IUnited States
-
Ultragenyx Pharmaceutical IncCompletedGSD1Netherlands, United States, Canada, Spain
-
Indiana UniversityCompletedLactose IntoleranceUnited States
-
Stanford UniversityCompleted
-
Baylor College of MedicineUniversity of Alabama at BirminghamCompleted
-
Ritter Pharmaceuticals, Inc.CompletedLactose IntoleranceUnited States
-
Glycomine, Inc.Recruiting24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDGPmm2-CDGSpain, Australia, United States
-
Purdue UniversityRecruiting
-
Vivante HealthDuke UniversityCompletedLactose IntoleranceUnited States
-
Ritter Pharmaceuticals, Inc.CompletedLactose IntoleranceUnited States
-
Purdue UniversityRecruitingLactose IntoleranceUnited States
-
Texas Tech UniversityVital Pharmaceuticals, Inc.CompletedEffects of a Caffeine- and Protein-Containing Coffee Beverage on Metabolism and Muscular PerformanceExercise Performance | MetabolismUnited States
-
Ultragenyx Pharmaceutical IncTerminatedGlycogen Storage Disease Type IIIUnited States, Netherlands
-
Eva Morava-KoziczNot yet recruitingPGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of GlycosylationUnited States
-
OxTheraCompletedPrimary HyperoxaluriaUnited States
-
Ritter Pharmaceuticals, Inc.CompletedLactose IntoleranceUnited States
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Orphan...CompletedHyperoxaluriaUnited States
-
University of MiamiHRSA/Maternal and Child Health BureauCompletedPhenylketonuria | Inborn Errors of Metabolism | GalactosemiaUnited States
-
Lundquist Institute for Biomedical Innovation at...Swedish Orphan Biovitrum; Cure Sanfilippo FoundationCompleted
-
Mayo ClinicCompleted
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Oxalosis...Completed
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States
-
Applied Therapeutics, Inc.Active, not recruiting
-
Duke UniversityRecruitingAdult Polyglucosan Body Disease | Glycogen Storage Disease Type IV | GSD4 | GSD IV | APBDUnited States
-
Ultragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IIIUnited States
-
Sanguine BiosciencesTerminatedGlycogen Storage Disease Type IBUnited States
-
Ultragenyx Pharmaceutical IncTerminatedGlycogen Storage Disease Type IIIUnited States, Spain, Italy
-
Applied Therapeutics, Inc.Active, not recruitingClassic GalactosemiaUnited States
-
Mayo ClinicChildren's Hospital of Philadelphia; Seattle Children's HospitalTerminated